• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. JRNY II BCS XLPE ART ISRT SZ 3-4-RT 9MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. JRNY II BCS XLPE ART ISRT SZ 3-4-RT 9MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Catalog Number 74027231
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Codes Pain (1994); Joint Dislocation (2374)
Date of Event 01/18/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Internal complaint number: (b)(4).
 
Event or Problem Description
It was reported that, after a tka surgery was performed on (b)(6) 2021, a revision surgery had to be carried out on (b)(6) 2024, since the jrny ii bcs xlpe art isrt sz 3-4-rt 9mm dislocated, and the patient experienced pain.The insert and patella were exchanged for s+n implants.Patent's current health status is unknown, further information is not available.
 
Additional Manufacturer Narrative
The device was not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, per complaint details, a revision was performed approximately 2.5 years post implantation due to insert dislocation and pain.Reportedly, the ¿surgeon doesn't think products failure¿, and the femoral component and tibial baseplate were retained while the insert and patella were exchanged for smith and nephew implants (patella revised from a biconvex to a resurfacing patella).It was communicated that the requested medical documentation was not available.Without the requested medical documentation, no contributing clinical factors were identified, the source of the dislocation cannot be isolated and a component mal performance cannot be concluded.The patient impact beyond the reported dislocation and pain with subsequent revision (insert exchange along with patella revision) cannot be determined, although a brief post-surgical recovery phase would be anticipated.A review of the production order did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history revealed similar events for the listed device over the previous 12 months, but no similar events for the batch based on the historical data, this failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for knee systems revealed that dislocation has been identified in possible adverse effects section as a result from trauma, improper implant selection, improper implant positioning, improper fixation, and/or migration of the components.Muscle and fibrous tissue laxity can also contribute to these conditions.A review of the risk management file revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this product and event.At this time, we have no evidence to conclude that the product failed to meet any specifications at the time of manufacture.Possible factors that could contribute to the reported event include traumatic injury or abnormal loading of limb.Based on this investigation, the need for corrective action is not indicated.Should the device or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JRNY II BCS XLPE ART ISRT SZ 3-4-RT 9MM
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key18693248
Report Number1020279-2024-00349
Device Sequence Number8357881
Product Code JWH
UDI-Device Identifier00885556179017
UDI-Public00885556179017
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K111711
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2024
Reporter Type Manufacturer
Report Source Other,Foreign
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 03/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue Number74027231
Device Lot Number21GM02583
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/18/2024
Supplement Date Received by Manufacturer03/22/2024
Initial Report FDA Received Date02/13/2024
Supplement Report FDA Received Date03/25/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/07/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device A
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
71420566 / GNS II BICONVEX PAT 23MM.; 74022115 / JRNY II BCS FEMORAL OXIN RT SZ 5.; 74022214 / JOURNEY TIBIA BASE NP RT SZ 4.
Patient SexFemale
-
-